Search all medical codes

GJB2 (gap junction protein, beta 2, 26kDa, connexin 26) (eg, nonsyndromic hearing loss) gene analysis; full gene sequence

CPT4 code

Gene Analysis for GJB2 (Connexin 26)

Name of the Procedure:

GJB2 (gap junction protein, beta 2, 26kDa, connexin 26), full gene sequence analysis; also known as Cx26 gene sequencing.

Summary

This is a genetic test that examines the entire GJB2 gene to identify mutations that can cause nonsyndromic hearing loss, a type of hearing impairment not associated with other symptoms.

Purpose

The GJB2 gene analysis aims to diagnose genetic hearing loss. By identifying mutations in the GJB2 gene, healthcare providers can determine the cause of hearing loss and guide appropriate treatment or management plans.

Indications

  • Individuals with congenital hearing loss.
  • Family history of nonsyndromic hearing loss.
  • Unexplained early hearing loss in children or adults.
  • Pre-symptomatic testing for at-risk family members.

Preparation

  • No special preparation, like fasting, is generally required.
  • A detailed family medical history may be taken.
  • A physical examination, including an audiometric assessment, might be performed.

Procedure Description

  1. Sample Collection: A small blood sample is typically collected from the patient. In some cases, a buccal swab (cheek swab) might be used instead.
  2. DNA Extraction: The DNA is extracted from the collected sample.
  3. Sequencing: The DNA undergoes sequencing to read the entire GJB2 gene.
  4. Analysis: Bioinformatics tools analyze the sequence data to identify any mutations.
  5. Report Generation: A geneticist interprets the results and generates a report.

Duration

The sample collection takes only a few minutes, but the sequencing and analysis process can take a few weeks.

Setting

The sample collection can be done in a clinic, hospital, or laboratory. The actual gene sequencing and analysis is carried out in a specialized genetic testing laboratory.

Personnel

  • Clinical geneticist or genetic counselor
  • Laboratory technicians or molecular biologists
  • Audiologist (for hearing assessments)
  • Healthcare providers for sample collection (e.g., nurses, phlebotomists)

Risks and Complications

The procedure is very low-risk:

  • Common: Minor discomfort or bruising at the site of blood draw.
  • Rare: No significant complications are associated with the gene sequencing itself.

Benefits

  • Accurate diagnosis of genetic hearing loss.
  • Informed decision-making for treatment and family planning.
  • Better understanding of the patient's condition and prognosis.

Recovery

  • No recovery time needed from the sample collection.
  • Follow-up appointments may be needed to discuss the results and their implications.

Alternatives

  • Targeted mutation analysis: Looks for specific common mutations in the GJB2 gene but may miss less common variants.
  • Comprehensive hearing loss gene panels: These analyze multiple genes associated with hearing loss, not just GJB2, providing a broader test at potentially higher cost and complexity.

Patient Experience

  • During the Procedure: Slight discomfort or brief pain during the blood draw.
  • After the Procedure: No physical recovery needed. Patients might experience anxiety while waiting for results, which can be managed with proper counseling and support.

--- This markdown text provides a thorough yet clear overview of the GJB2 gene analysis procedure for nonsyndromic hearing loss, designed to be accessible to both medical professionals and patients.

Similar Codes